Name | 1-(3-hexanoyl-2,4,6-trihydroxyphenyl)hexan-1-one |
---|---|
Synonyms | Hyp9 |
Description | Hyp9 is a transient receptor potential canonical 6 (TRPC6)-specific agonist. Hyp9 can be used for the research of spinal cord injury (SCI)[1]. |
---|---|
Related Catalog | |
In Vitro | HYP9 (0, 1, 5, 10, 15, 20, 25, 30 µM; 72 h) 以剂量依赖性方式抑制星形胶质细胞增殖[1]。 HYP9 显著抑制 AP4 过表达[1]。 Cell Proliferation Assay[1] Cell Line: CTX-TNA2 rat astrocytes Concentration: 0, 1, 5, 10, 15, 20, 25, 30 µM Incubation Time: 72 h Result: Significantly inhibit astrocyte proliferation at 5-30 µM. |
In Vivo | HP9(鞘内注射;5 μg;1、3、5 和 7 天)通过抑制 SCl 大鼠体内模型中的 AQP4 来抑制星形胶质细胞的活化和增殖,并在 SCI 后保持神经元存活和功能恢复[1]。 Animal Model: Sprague-Dawley Rats (180-220 g; adult female)[1] Dosage: 5 μg Administration: Intrathecally; 1, 3, 5, and 7 days Result: Inhibited activation and proliferation of astrocytes in a rat SCI model. Reduced apoptosis and promotes neuronal survival in SCI rats by TRPC6/AQP4 signaling pathway. Facilitated functional motor recovery via TRPC6/AQP4 signaling pathway in SCI rats. |
References |
Melting Point | 97 - 98 °C |
---|---|
Molecular Formula | C18H26O5 |
Molecular Weight | 322.39600 |
Exact Mass | 322.17800 |
PSA | 94.83000 |
LogP | 4.32940 |
Storage condition | 2-8°C |
RIDADR | NONH for all modes of transport |
---|---|
HS Code | 2914400090 |
~% 3118-34-1 |
Literature: Chiba; Takakuwa; Tada; Yoshii Bioscience, biotechnology, and biochemistry, 1992 , vol. 56, # 11 p. 1769 - 1772 |
~% 3118-34-1 |
Literature: Bolte, Matthew L.; Crow, Wilfrid D.; Takahashi, Nobutaka; Sakurai, Akira; Uji-Ie, Masami; Yoshida, Shigeo Agricultural and Biological Chemistry, 1985 , vol. 49, # 3 p. 761 - 768 |
HS Code | 2914400090 |
---|---|
Summary | 2914400090 other ketone-alcohols and ketone-aldehydes。Supervision conditions:None。VAT:17.0%。Tax rebate rate:9.0%。MFN tariff:5.5%。General tariff:30.0% |